nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproterone acetate—AR—hematologic cancer	0.249	0.596	CbGaD
Cyproterone acetate—NR3C1—hematologic cancer	0.169	0.404	CbGaD
Cyproterone acetate—NR3C1—Triamcinolone—hematologic cancer	0.049	0.182	CbGbCtD
Cyproterone acetate—CYP19A1—Betamethasone—hematologic cancer	0.0463	0.172	CbGbCtD
Cyproterone acetate—NR3C1—Betamethasone—hematologic cancer	0.0421	0.156	CbGbCtD
Cyproterone acetate—NR3C1—Prednisolone—hematologic cancer	0.0415	0.154	CbGbCtD
Cyproterone acetate—NR3C1—Prednisone—hematologic cancer	0.0392	0.145	CbGbCtD
Cyproterone acetate—CYP19A1—Dexamethasone—hematologic cancer	0.027	0.1	CbGbCtD
Cyproterone acetate—NR3C1—Dexamethasone—hematologic cancer	0.0245	0.0908	CbGbCtD
Cyproterone acetate—CYP19A1—ovarian follicle—hematologic cancer	0.0135	0.458	CbGeAlD
Cyproterone acetate—CYP19A1—hematopoietic system—hematologic cancer	0.00163	0.0553	CbGeAlD
Cyproterone acetate—AR—hematopoietic system—hematologic cancer	0.00144	0.0489	CbGeAlD
Cyproterone acetate—CYP19A1—gonad—hematologic cancer	0.00124	0.042	CbGeAlD
Cyproterone acetate—AR—gonad—hematologic cancer	0.0011	0.0372	CbGeAlD
Cyproterone acetate—CYP19A1—blood—hematologic cancer	0.00108	0.0366	CbGeAlD
Cyproterone acetate—NR3C1—hematopoietic system—hematologic cancer	0.00105	0.0354	CbGeAlD
Cyproterone acetate—AR—blood—hematologic cancer	0.000957	0.0324	CbGeAlD
Cyproterone acetate—CYP19A1—testis—hematologic cancer	0.000894	0.0303	CbGeAlD
Cyproterone acetate—AR—lung—hematologic cancer	0.000839	0.0284	CbGeAlD
Cyproterone acetate—NR3C1—gonad—hematologic cancer	0.000795	0.027	CbGeAlD
Cyproterone acetate—AR—testis—hematologic cancer	0.000791	0.0268	CbGeAlD
Cyproterone acetate—NR3C1—blood—hematologic cancer	0.000693	0.0235	CbGeAlD
Cyproterone acetate—NR3C1—bone marrow—hematologic cancer	0.00067	0.0227	CbGeAlD
Cyproterone acetate—CYP19A1—lymph node—hematologic cancer	0.000648	0.022	CbGeAlD
Cyproterone acetate—Ethynodiol—ESR1—hematologic cancer	0.000637	0.302	CrCbGaD
Cyproterone acetate—NR3C1—lung—hematologic cancer	0.000607	0.0206	CbGeAlD
Cyproterone acetate—AR—lymph node—hematologic cancer	0.000574	0.0194	CbGeAlD
Cyproterone acetate—NR3C1—testis—hematologic cancer	0.000573	0.0194	CbGeAlD
Cyproterone acetate—NR3C1—lymph node—hematologic cancer	0.000415	0.0141	CbGeAlD
Cyproterone acetate—Megestrol acetate—NR3C1—hematologic cancer	0.00041	0.195	CrCbGaD
Cyproterone acetate—Medroxyprogesterone Acetate—AR—hematologic cancer	0.000352	0.167	CrCbGaD
Cyproterone acetate—Medroxyprogesterone Acetate—ESR1—hematologic cancer	0.000271	0.129	CrCbGaD
Cyproterone acetate—Medroxyprogesterone Acetate—NR3C1—hematologic cancer	0.000239	0.113	CrCbGaD
Cyproterone acetate—Megestrol acetate—ABCB1—hematologic cancer	0.000198	0.0939	CrCbGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—hematologic cancer	4.3e-05	0.000593	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	4.26e-05	0.000588	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—hematologic cancer	4.26e-05	0.000587	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CREB1—hematologic cancer	4.25e-05	0.000586	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—CREB1—hematologic cancer	4.22e-05	0.000583	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	4.21e-05	0.000581	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—BRAF—hematologic cancer	4.2e-05	0.000579	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CASP8—hematologic cancer	4.16e-05	0.000574	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—hematologic cancer	4.16e-05	0.000573	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—BCL2—hematologic cancer	4.15e-05	0.000572	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SMPD3—hematologic cancer	4.13e-05	0.00057	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—RB1—hematologic cancer	4.12e-05	0.000569	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	4.12e-05	0.000569	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—RB1—hematologic cancer	4.1e-05	0.000565	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CREB1—hematologic cancer	4.09e-05	0.000564	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—hematologic cancer	4.09e-05	0.000564	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—POLR3E—hematologic cancer	4.09e-05	0.000564	CbGpPWpGaD
Cyproterone acetate—NR3C1—Endoderm Differentiation—TGFB1—hematologic cancer	4.09e-05	0.000564	CbGpPWpGaD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—AKT1—hematologic cancer	4.09e-05	0.000564	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—MDM2—hematologic cancer	4.09e-05	0.000564	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—EP300—hematologic cancer	4.05e-05	0.000559	CbGpPWpGaD
Cyproterone acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—hematologic cancer	4.03e-05	0.000556	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—MYC—hematologic cancer	4.01e-05	0.000553	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CASP8—hematologic cancer	4e-05	0.000552	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—TGFB1—hematologic cancer	4e-05	0.000551	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CREBBP—hematologic cancer	3.99e-05	0.00055	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—MTOR—hematologic cancer	3.98e-05	0.000548	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—PARP1—hematologic cancer	3.93e-05	0.000543	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	3.85e-05	0.000531	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MAP2K1—hematologic cancer	3.8e-05	0.000525	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	3.75e-05	0.000518	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CASP3—hematologic cancer	3.66e-05	0.000504	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CREB1—hematologic cancer	3.65e-05	0.000504	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—hematologic cancer	3.63e-05	0.000501	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—FGF2—hematologic cancer	3.62e-05	0.000499	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—DCK—hematologic cancer	3.61e-05	0.000498	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ASNS—hematologic cancer	3.61e-05	0.000498	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—B3GAT1—hematologic cancer	3.61e-05	0.000498	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL1B—hematologic cancer	3.57e-05	0.000493	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—BCL2—hematologic cancer	3.57e-05	0.000492	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—hematologic cancer	3.56e-05	0.000492	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—CASP3—hematologic cancer	3.56e-05	0.000491	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL6R—hematologic cancer	3.56e-05	0.000491	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CCND1—hematologic cancer	3.56e-05	0.000491	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CREBBP—hematologic cancer	3.56e-05	0.00049	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—JUN—hematologic cancer	3.55e-05	0.00049	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—RARA—hematologic cancer	3.55e-05	0.000489	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—TET2—hematologic cancer	3.55e-05	0.000489	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	3.53e-05	0.000487	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—MDM2—hematologic cancer	3.52e-05	0.000485	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—RPLP1—hematologic cancer	3.48e-05	0.00048	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—JUN—hematologic cancer	3.46e-05	0.000477	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	3.44e-05	0.000474	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—PTEN—hematologic cancer	3.44e-05	0.000474	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—HDC—hematologic cancer	3.42e-05	0.000472	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—MTOR—hematologic cancer	3.42e-05	0.000472	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	3.39e-05	0.000467	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—RARS—hematologic cancer	3.3e-05	0.000455	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—NR0B2—hematologic cancer	3.3e-05	0.000455	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—TP53—hematologic cancer	3.29e-05	0.000454	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—EP300—hematologic cancer	3.28e-05	0.000452	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—hematologic cancer	3.26e-05	0.000449	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	3.19e-05	0.00044	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—EP300—hematologic cancer	3.19e-05	0.00044	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CASP3—hematologic cancer	3.15e-05	0.000434	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—DNMT3A—hematologic cancer	3.15e-05	0.000434	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CDA—hematologic cancer	3.13e-05	0.000432	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—POLR3E—hematologic cancer	3.1e-05	0.000428	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—VEGFA—hematologic cancer	3.1e-05	0.000428	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—ELL—hematologic cancer	3.1e-05	0.000428	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	3.09e-05	0.000426	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CCND1—hematologic cancer	3.06e-05	0.000422	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—JUN—hematologic cancer	3.06e-05	0.000422	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—CDKN2B—hematologic cancer	3.03e-05	0.000418	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	3.03e-05	0.000418	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—VEGFA—hematologic cancer	3.02e-05	0.000417	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—AKT1—hematologic cancer	3.02e-05	0.000417	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PC—hematologic cancer	3.01e-05	0.000416	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IL6—hematologic cancer	3.01e-05	0.000415	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—PARP1—hematologic cancer	2.98e-05	0.000412	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—NCOR2—hematologic cancer	2.98e-05	0.000411	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—PTEN—hematologic cancer	2.96e-05	0.000408	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	2.95e-05	0.000407	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—CDKN1A—hematologic cancer	2.94e-05	0.000406	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	2.94e-05	0.000406	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SLC35B2—hematologic cancer	2.91e-05	0.000402	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GBA—hematologic cancer	2.91e-05	0.000402	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—TP53—hematologic cancer	2.9e-05	0.0004	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—NCOR1—hematologic cancer	2.88e-05	0.000397	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—MYC—hematologic cancer	2.86e-05	0.000394	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	2.85e-05	0.000394	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	2.85e-05	0.000393	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—EP300—hematologic cancer	2.82e-05	0.000389	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	2.78e-05	0.000384	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—AGO2—hematologic cancer	2.74e-05	0.000378	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	2.71e-05	0.000374	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL1B—hematologic cancer	2.71e-05	0.000374	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CASP3—hematologic cancer	2.7e-05	0.000373	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—RARA—hematologic cancer	2.69e-05	0.000371	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—TET2—hematologic cancer	2.69e-05	0.000371	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—DNMT3B—hematologic cancer	2.69e-05	0.000371	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—H3F3B—hematologic cancer	2.69e-05	0.000371	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—hematologic cancer	2.67e-05	0.000368	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—MTAP—hematologic cancer	2.66e-05	0.000367	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—NR3C1—hematologic cancer	2.66e-05	0.000367	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IL6—hematologic cancer	2.65e-05	0.000366	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	2.64e-05	0.000364	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—RPLP1—hematologic cancer	2.64e-05	0.000364	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—KRAS—hematologic cancer	2.64e-05	0.000364	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—STAT3—hematologic cancer	2.63e-05	0.000362	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—JUN—hematologic cancer	2.63e-05	0.000362	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—TNF—hematologic cancer	2.59e-05	0.000357	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	2.57e-05	0.000355	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—NR0B2—hematologic cancer	2.5e-05	0.000345	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—AR—hematologic cancer	2.5e-05	0.000344	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—hematologic cancer	2.47e-05	0.000341	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—RPS14—hematologic cancer	2.46e-05	0.000339	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—MYC—hematologic cancer	2.46e-05	0.000339	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—hematologic cancer	2.45e-05	0.000338	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—TGFB1—hematologic cancer	2.44e-05	0.000336	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	2.43e-05	0.000335	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—EP300—hematologic cancer	2.42e-05	0.000334	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—NUP98—hematologic cancer	2.42e-05	0.000334	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—DNMT3A—hematologic cancer	2.39e-05	0.000329	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—FHL2—hematologic cancer	2.37e-05	0.000327	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	2.37e-05	0.000326	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	2.36e-05	0.000326	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—ELL—hematologic cancer	2.35e-05	0.000324	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—TP53—hematologic cancer	2.34e-05	0.000323	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—NUP214—hematologic cancer	2.33e-05	0.000322	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—AGRN—hematologic cancer	2.33e-05	0.000321	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—CDKN2B—hematologic cancer	2.3e-05	0.000317	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—VEGFA—hematologic cancer	2.29e-05	0.000316	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—TNF—hematologic cancer	2.27e-05	0.000314	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—KRAS—hematologic cancer	2.27e-05	0.000313	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—ESR1—hematologic cancer	2.26e-05	0.000312	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—NCOR2—hematologic cancer	2.26e-05	0.000311	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—IDH2—hematologic cancer	2.21e-05	0.000304	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—HMMR—hematologic cancer	2.21e-05	0.000304	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	2.2e-05	0.000304	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	2.19e-05	0.000301	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—NOTCH1—hematologic cancer	2.18e-05	0.000301	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—NCOR1—hematologic cancer	2.18e-05	0.000301	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—EIF4EBP1—hematologic cancer	2.15e-05	0.000296	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—HSPB1—hematologic cancer	2.15e-05	0.000296	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL6—hematologic cancer	2.09e-05	0.000288	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—AGO2—hematologic cancer	2.08e-05	0.000287	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	2.08e-05	0.000287	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ARNTL—hematologic cancer	2.07e-05	0.000286	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—SMC1A—hematologic cancer	2.06e-05	0.000284	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—DNMT3B—hematologic cancer	2.04e-05	0.000281	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—H3F3B—hematologic cancer	2.04e-05	0.000281	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CA9—hematologic cancer	2.02e-05	0.000278	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ACP5—hematologic cancer	2.02e-05	0.000278	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—TP53—hematologic cancer	2.02e-05	0.000278	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—H3F3A—hematologic cancer	2.02e-05	0.000278	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	2.01e-05	0.000277	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—NCOR2—hematologic cancer	1.99e-05	0.000275	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—CREBBP—hematologic cancer	1.98e-05	0.000273	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—AKT1—hematologic cancer	1.98e-05	0.000273	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—TNF—hematologic cancer	1.97e-05	0.000271	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	1.94e-05	0.000268	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—EZH2—hematologic cancer	1.93e-05	0.000267	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—IDH1—hematologic cancer	1.9e-05	0.000262	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—PARP1—hematologic cancer	1.89e-05	0.000261	CbGpPWpGaD
Cyproterone acetate—Chills—Methotrexate—hematologic cancer	1.88e-05	9.02e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—ABCC3—hematologic cancer	1.88e-05	0.000259	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—TXN—hematologic cancer	1.88e-05	0.000259	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GSTO1—hematologic cancer	1.88e-05	0.000259	CbGpPWpGaD
Cyproterone acetate—Headache—Mitoxantrone—hematologic cancer	1.87e-05	8.98e-05	CcSEcCtD
Cyproterone acetate—Headache—Irinotecan—hematologic cancer	1.87e-05	8.98e-05	CcSEcCtD
Cyproterone acetate—Nausea—Ifosfamide—hematologic cancer	1.87e-05	8.97e-05	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—RPS14—hematologic cancer	1.87e-05	0.000257	CbGpPWpGaD
Cyproterone acetate—Feeling abnormal—Triamcinolone—hematologic cancer	1.86e-05	8.91e-05	CcSEcCtD
Cyproterone acetate—Diarrhoea—Cisplatin—hematologic cancer	1.86e-05	8.91e-05	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Epirubicin—hematologic cancer	1.86e-05	8.89e-05	CcSEcCtD
Cyproterone acetate—Alopecia—Methotrexate—hematologic cancer	1.85e-05	8.88e-05	CcSEcCtD
Cyproterone acetate—Vomiting—Gemcitabine—hematologic cancer	1.85e-05	8.88e-05	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	1.85e-05	8.85e-05	CcSEcCtD
Cyproterone acetate—Discomfort—Prednisone—hematologic cancer	1.84e-05	8.81e-05	CcSEcCtD
Cyproterone acetate—Mental disorder—Methotrexate—hematologic cancer	1.84e-05	8.81e-05	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—NUP98—hematologic cancer	1.84e-05	0.000253	CbGpPWpGaD
Cyproterone acetate—Rash—Gemcitabine—hematologic cancer	1.84e-05	8.8e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—SPHK1—hematologic cancer	1.84e-05	0.000253	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—IL6—hematologic cancer	1.84e-05	0.000253	CbGpPWpGaD
Cyproterone acetate—Dermatitis—Gemcitabine—hematologic cancer	1.83e-05	8.8e-05	CcSEcCtD
Cyproterone acetate—Eye disorder—Epirubicin—hematologic cancer	1.83e-05	8.79e-05	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Etoposide—hematologic cancer	1.83e-05	8.78e-05	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—HDAC2—hematologic cancer	1.83e-05	0.000252	CbGpPWpGaD
Cyproterone acetate—Malnutrition—Methotrexate—hematologic cancer	1.83e-05	8.75e-05	CcSEcCtD
Cyproterone acetate—Haemoglobin—Doxorubicin—hematologic cancer	1.82e-05	8.75e-05	CcSEcCtD
Cyproterone acetate—Headache—Gemcitabine—hematologic cancer	1.82e-05	8.75e-05	CcSEcCtD
Cyproterone acetate—Nausea—Vincristine—hematologic cancer	1.82e-05	8.74e-05	CcSEcCtD
Cyproterone acetate—Haemorrhage—Doxorubicin—hematologic cancer	1.82e-05	8.7e-05	CcSEcCtD
Cyproterone acetate—Hepatitis—Doxorubicin—hematologic cancer	1.82e-05	8.7e-05	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Prednisolone—hematologic cancer	1.81e-05	8.66e-05	CcSEcCtD
Cyproterone acetate—Dyspepsia—Betamethasone—hematologic cancer	1.8e-05	8.64e-05	CcSEcCtD
Cyproterone acetate—Dyspepsia—Dexamethasone—hematologic cancer	1.8e-05	8.64e-05	CcSEcCtD
Cyproterone acetate—Urticaria—Triamcinolone—hematologic cancer	1.79e-05	8.59e-05	CcSEcCtD
Cyproterone acetate—Asthenia—Etoposide—hematologic cancer	1.78e-05	8.55e-05	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Doxorubicin—hematologic cancer	1.78e-05	8.55e-05	CcSEcCtD
Cyproterone acetate—Body temperature increased—Triamcinolone—hematologic cancer	1.78e-05	8.55e-05	CcSEcCtD
Cyproterone acetate—Oedema—Prednisone—hematologic cancer	1.78e-05	8.55e-05	CcSEcCtD
Cyproterone acetate—Angiopathy—Epirubicin—hematologic cancer	1.78e-05	8.54e-05	CcSEcCtD
Cyproterone acetate—Decreased appetite—Betamethasone—hematologic cancer	1.78e-05	8.53e-05	CcSEcCtD
Cyproterone acetate—Decreased appetite—Dexamethasone—hematologic cancer	1.78e-05	8.53e-05	CcSEcCtD
Cyproterone acetate—Nausea—Irinotecan—hematologic cancer	1.78e-05	8.51e-05	CcSEcCtD
Cyproterone acetate—Nausea—Mitoxantrone—hematologic cancer	1.78e-05	8.51e-05	CcSEcCtD
Cyproterone acetate—Immune system disorder—Epirubicin—hematologic cancer	1.77e-05	8.5e-05	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—NUP214—hematologic cancer	1.77e-05	0.000244	CbGpPWpGaD
Cyproterone acetate—Mediastinal disorder—Epirubicin—hematologic cancer	1.77e-05	8.48e-05	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Betamethasone—hematologic cancer	1.77e-05	8.47e-05	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Dexamethasone—hematologic cancer	1.77e-05	8.47e-05	CcSEcCtD
Cyproterone acetate—Fatigue—Dexamethasone—hematologic cancer	1.76e-05	8.46e-05	CcSEcCtD
Cyproterone acetate—Fatigue—Betamethasone—hematologic cancer	1.76e-05	8.46e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—UGT1A1—hematologic cancer	1.76e-05	0.000243	CbGpPWpGaD
Cyproterone acetate—Chills—Epirubicin—hematologic cancer	1.76e-05	8.44e-05	CcSEcCtD
Cyproterone acetate—Pruritus—Etoposide—hematologic cancer	1.76e-05	8.44e-05	CcSEcCtD
Cyproterone acetate—Shock—Prednisone—hematologic cancer	1.75e-05	8.41e-05	CcSEcCtD
Cyproterone acetate—Visual impairment—Doxorubicin—hematologic cancer	1.75e-05	8.39e-05	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Prednisone—hematologic cancer	1.75e-05	8.38e-05	CcSEcCtD
Cyproterone acetate—Tachycardia—Prednisone—hematologic cancer	1.74e-05	8.34e-05	CcSEcCtD
Cyproterone acetate—Alopecia—Epirubicin—hematologic cancer	1.73e-05	8.31e-05	CcSEcCtD
Cyproterone acetate—Skin disorder—Prednisone—hematologic cancer	1.73e-05	8.3e-05	CcSEcCtD
Cyproterone acetate—Nausea—Gemcitabine—hematologic cancer	1.73e-05	8.29e-05	CcSEcCtD
Cyproterone acetate—Vomiting—Cisplatin—hematologic cancer	1.73e-05	8.28e-05	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Prednisone—hematologic cancer	1.72e-05	8.26e-05	CcSEcCtD
Cyproterone acetate—Mental disorder—Epirubicin—hematologic cancer	1.72e-05	8.24e-05	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Doxorubicin—hematologic cancer	1.72e-05	8.23e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—CRABP1—hematologic cancer	1.72e-05	0.000237	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SLC22A1—hematologic cancer	1.72e-05	0.000237	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—ESR1—hematologic cancer	1.71e-05	0.000236	CbGpPWpGaD
Cyproterone acetate—Rash—Cisplatin—hematologic cancer	1.71e-05	8.21e-05	CcSEcCtD
Cyproterone acetate—Dermatitis—Cisplatin—hematologic cancer	1.71e-05	8.2e-05	CcSEcCtD
Cyproterone acetate—Malnutrition—Epirubicin—hematologic cancer	1.71e-05	8.19e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—hematologic cancer	1.7e-05	0.000235	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Etoposide—hematologic cancer	1.7e-05	8.16e-05	CcSEcCtD
Cyproterone acetate—Anorexia—Prednisone—hematologic cancer	1.7e-05	8.15e-05	CcSEcCtD
Cyproterone acetate—Eye disorder—Doxorubicin—hematologic cancer	1.7e-05	8.13e-05	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Methotrexate—hematologic cancer	1.69e-05	8.12e-05	CcSEcCtD
Cyproterone acetate—Anaemia—Methotrexate—hematologic cancer	1.69e-05	8.09e-05	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Dexamethasone—hematologic cancer	1.69e-05	8.09e-05	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Betamethasone—hematologic cancer	1.69e-05	8.09e-05	CcSEcCtD
Cyproterone acetate—Tension—Epirubicin—hematologic cancer	1.68e-05	8.04e-05	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Betamethasone—hematologic cancer	1.67e-05	8.02e-05	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.67e-05	8.02e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—ALOX5—hematologic cancer	1.67e-05	0.000231	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Triamcinolone—hematologic cancer	1.66e-05	7.97e-05	CcSEcCtD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—NOTCH1—hematologic cancer	1.66e-05	0.000229	CbGpPWpGaD
Cyproterone acetate—Angiopathy—Doxorubicin—hematologic cancer	1.65e-05	7.9e-05	CcSEcCtD
Cyproterone acetate—Malaise—Methotrexate—hematologic cancer	1.65e-05	7.89e-05	CcSEcCtD
Cyproterone acetate—Dizziness—Etoposide—hematologic cancer	1.64e-05	7.88e-05	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	1.64e-05	0.000226	CbGpPWpGaD
Cyproterone acetate—Immune system disorder—Doxorubicin—hematologic cancer	1.64e-05	7.86e-05	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Doxorubicin—hematologic cancer	1.64e-05	7.84e-05	CcSEcCtD
Cyproterone acetate—Leukopenia—Methotrexate—hematologic cancer	1.63e-05	7.83e-05	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—EIF4EBP1—hematologic cancer	1.63e-05	0.000225	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—HSPB1—hematologic cancer	1.63e-05	0.000225	CbGpPWpGaD
Cyproterone acetate—Chills—Doxorubicin—hematologic cancer	1.63e-05	7.81e-05	CcSEcCtD
Cyproterone acetate—Urticaria—Dexamethasone—hematologic cancer	1.63e-05	7.8e-05	CcSEcCtD
Cyproterone acetate—Urticaria—Betamethasone—hematologic cancer	1.63e-05	7.8e-05	CcSEcCtD
Cyproterone acetate—Dizziness—Prednisolone—hematologic cancer	1.62e-05	7.78e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—NUP98—hematologic cancer	1.62e-05	0.000223	CbGpPWpGaD
Cyproterone acetate—Asthenia—Triamcinolone—hematologic cancer	1.62e-05	7.76e-05	CcSEcCtD
Cyproterone acetate—Body temperature increased—Dexamethasone—hematologic cancer	1.62e-05	7.76e-05	CcSEcCtD
Cyproterone acetate—Abdominal pain—Dexamethasone—hematologic cancer	1.62e-05	7.76e-05	CcSEcCtD
Cyproterone acetate—Abdominal pain—Betamethasone—hematologic cancer	1.62e-05	7.76e-05	CcSEcCtD
Cyproterone acetate—Body temperature increased—Betamethasone—hematologic cancer	1.62e-05	7.76e-05	CcSEcCtD
Cyproterone acetate—Nausea—Cisplatin—hematologic cancer	1.61e-05	7.73e-05	CcSEcCtD
Cyproterone acetate—Alopecia—Doxorubicin—hematologic cancer	1.6e-05	7.69e-05	CcSEcCtD
Cyproterone acetate—Pruritus—Triamcinolone—hematologic cancer	1.6e-05	7.65e-05	CcSEcCtD
Cyproterone acetate—Cough—Methotrexate—hematologic cancer	1.59e-05	7.64e-05	CcSEcCtD
Cyproterone acetate—Mental disorder—Doxorubicin—hematologic cancer	1.59e-05	7.63e-05	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL6—hematologic cancer	1.59e-05	0.000219	CbGpPWpGaD
Cyproterone acetate—Ill-defined disorder—Epirubicin—hematologic cancer	1.58e-05	7.6e-05	CcSEcCtD
Cyproterone acetate—Vomiting—Etoposide—hematologic cancer	1.58e-05	7.58e-05	CcSEcCtD
Cyproterone acetate—Malnutrition—Doxorubicin—hematologic cancer	1.58e-05	7.58e-05	CcSEcCtD
Cyproterone acetate—Anaemia—Epirubicin—hematologic cancer	1.58e-05	7.57e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—ADCY7—hematologic cancer	1.57e-05	0.000217	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—NCOA3—hematologic cancer	1.57e-05	0.000217	CbGpPWpGaD
Cyproterone acetate—Agitation—Epirubicin—hematologic cancer	1.57e-05	7.53e-05	CcSEcCtD
Cyproterone acetate—Dyspepsia—Prednisone—hematologic cancer	1.57e-05	7.52e-05	CcSEcCtD
Cyproterone acetate—Rash—Etoposide—hematologic cancer	1.57e-05	7.52e-05	CcSEcCtD
Cyproterone acetate—Dermatitis—Etoposide—hematologic cancer	1.57e-05	7.51e-05	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—SMC1A—hematologic cancer	1.56e-05	0.000215	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—NUP214—hematologic cancer	1.56e-05	0.000215	CbGpPWpGaD
Cyproterone acetate—Headache—Etoposide—hematologic cancer	1.56e-05	7.47e-05	CcSEcCtD
Cyproterone acetate—Tension—Doxorubicin—hematologic cancer	1.55e-05	7.44e-05	CcSEcCtD
Cyproterone acetate—Decreased appetite—Prednisone—hematologic cancer	1.55e-05	7.43e-05	CcSEcCtD
Cyproterone acetate—Rash—Prednisolone—hematologic cancer	1.55e-05	7.42e-05	CcSEcCtD
Cyproterone acetate—Dermatitis—Prednisolone—hematologic cancer	1.54e-05	7.41e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.54e-05	0.000213	CbGpPWpGaD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.54e-05	7.4e-05	CcSEcCtD
Cyproterone acetate—Malaise—Epirubicin—hematologic cancer	1.54e-05	7.39e-05	CcSEcCtD
Cyproterone acetate—Fatigue—Prednisone—hematologic cancer	1.54e-05	7.37e-05	CcSEcCtD
Cyproterone acetate—Headache—Prednisolone—hematologic cancer	1.54e-05	7.37e-05	CcSEcCtD
Cyproterone acetate—Discomfort—Methotrexate—hematologic cancer	1.54e-05	7.36e-05	CcSEcCtD
Cyproterone acetate—Syncope—Epirubicin—hematologic cancer	1.53e-05	7.34e-05	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—H3F3A—hematologic cancer	1.53e-05	0.000211	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—MTR—hematologic cancer	1.53e-05	0.000211	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ABCG2—hematologic cancer	1.53e-05	0.000211	CbGpPWpGaD
Cyproterone acetate—Leukopenia—Epirubicin—hematologic cancer	1.53e-05	7.33e-05	CcSEcCtD
Cyproterone acetate—Constipation—Prednisone—hematologic cancer	1.52e-05	7.31e-05	CcSEcCtD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—CREBBP—hematologic cancer	1.5e-05	0.000207	CbGpPWpGaD
Cyproterone acetate—Loss of consciousness—Epirubicin—hematologic cancer	1.5e-05	7.2e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—ENO2—hematologic cancer	1.5e-05	0.000207	CbGpPWpGaD
Cyproterone acetate—Dizziness—Triamcinolone—hematologic cancer	1.49e-05	7.15e-05	CcSEcCtD
Cyproterone acetate—Cough—Epirubicin—hematologic cancer	1.49e-05	7.15e-05	CcSEcCtD
Cyproterone acetate—Nausea—Etoposide—hematologic cancer	1.48e-05	7.08e-05	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Prednisone—hematologic cancer	1.47e-05	7.04e-05	CcSEcCtD
Cyproterone acetate—Asthenia—Betamethasone—hematologic cancer	1.47e-05	7.04e-05	CcSEcCtD
Cyproterone acetate—Asthenia—Dexamethasone—hematologic cancer	1.47e-05	7.04e-05	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—EZH2—hematologic cancer	1.47e-05	0.000202	CbGpPWpGaD
Cyproterone acetate—Ill-defined disorder—Doxorubicin—hematologic cancer	1.47e-05	7.03e-05	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Methotrexate—hematologic cancer	1.46e-05	7e-05	CcSEcCtD
Cyproterone acetate—Anaemia—Doxorubicin—hematologic cancer	1.46e-05	7e-05	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—CDKN2B—hematologic cancer	1.46e-05	0.000201	CbGpPWpGaD
Cyproterone acetate—Thrombocytopenia—Methotrexate—hematologic cancer	1.46e-05	6.99e-05	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Prednisone—hematologic cancer	1.46e-05	6.99e-05	CcSEcCtD
Cyproterone acetate—Nausea—Prednisolone—hematologic cancer	1.46e-05	6.99e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—GSTT1—hematologic cancer	1.45e-05	0.000201	CbGpPWpGaD
Cyproterone acetate—Agitation—Doxorubicin—hematologic cancer	1.45e-05	6.96e-05	CcSEcCtD
Cyproterone acetate—Pruritus—Betamethasone—hematologic cancer	1.45e-05	6.94e-05	CcSEcCtD
Cyproterone acetate—Pruritus—Dexamethasone—hematologic cancer	1.45e-05	6.94e-05	CcSEcCtD
Cyproterone acetate—Skin disorder—Methotrexate—hematologic cancer	1.45e-05	6.94e-05	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.44e-05	6.92e-05	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Methotrexate—hematologic cancer	1.44e-05	6.9e-05	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—PARP1—hematologic cancer	1.44e-05	0.000198	CbGpPWpGaD
Cyproterone acetate—Discomfort—Epirubicin—hematologic cancer	1.44e-05	6.89e-05	CcSEcCtD
Cyproterone acetate—Vomiting—Triamcinolone—hematologic cancer	1.43e-05	6.88e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.43e-05	0.000198	CbGpPWpGaD
Cyproterone acetate—Malaise—Doxorubicin—hematologic cancer	1.43e-05	6.83e-05	CcSEcCtD
Cyproterone acetate—Rash—Triamcinolone—hematologic cancer	1.42e-05	6.82e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—SDC1—hematologic cancer	1.42e-05	0.000196	CbGpPWpGaD
Cyproterone acetate—Dermatitis—Triamcinolone—hematologic cancer	1.42e-05	6.81e-05	CcSEcCtD
Cyproterone acetate—Anorexia—Methotrexate—hematologic cancer	1.42e-05	6.81e-05	CcSEcCtD
Cyproterone acetate—Syncope—Doxorubicin—hematologic cancer	1.42e-05	6.8e-05	CcSEcCtD
Cyproterone acetate—Urticaria—Prednisone—hematologic cancer	1.42e-05	6.79e-05	CcSEcCtD
Cyproterone acetate—Leukopenia—Doxorubicin—hematologic cancer	1.41e-05	6.78e-05	CcSEcCtD
Cyproterone acetate—Headache—Triamcinolone—hematologic cancer	1.41e-05	6.78e-05	CcSEcCtD
Cyproterone acetate—Abdominal pain—Prednisone—hematologic cancer	1.41e-05	6.76e-05	CcSEcCtD
Cyproterone acetate—Body temperature increased—Prednisone—hematologic cancer	1.41e-05	6.76e-05	CcSEcCtD
Cyproterone acetate—Diarrhoea—Betamethasone—hematologic cancer	1.4e-05	6.71e-05	CcSEcCtD
Cyproterone acetate—Diarrhoea—Dexamethasone—hematologic cancer	1.4e-05	6.71e-05	CcSEcCtD
Cyproterone acetate—Oedema—Epirubicin—hematologic cancer	1.39e-05	6.68e-05	CcSEcCtD
Cyproterone acetate—Hypotension—Methotrexate—hematologic cancer	1.39e-05	6.67e-05	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Doxorubicin—hematologic cancer	1.39e-05	6.66e-05	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—HDAC2—hematologic cancer	1.39e-05	0.000191	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—NCOR1—hematologic cancer	1.38e-05	0.000191	CbGpPWpGaD
Cyproterone acetate—Cough—Doxorubicin—hematologic cancer	1.38e-05	6.61e-05	CcSEcCtD
Cyproterone acetate—Shock—Epirubicin—hematologic cancer	1.37e-05	6.58e-05	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Epirubicin—hematologic cancer	1.37e-05	6.55e-05	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Epirubicin—hematologic cancer	1.36e-05	6.54e-05	CcSEcCtD
Cyproterone acetate—Tachycardia—Epirubicin—hematologic cancer	1.36e-05	6.52e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.36e-05	0.000187	CbGpPWpGaD
Cyproterone acetate—Skin disorder—Epirubicin—hematologic cancer	1.35e-05	6.49e-05	CcSEcCtD
Cyproterone acetate—Dizziness—Dexamethasone—hematologic cancer	1.35e-05	6.49e-05	CcSEcCtD
Cyproterone acetate—Dizziness—Betamethasone—hematologic cancer	1.35e-05	6.49e-05	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Epirubicin—hematologic cancer	1.35e-05	6.46e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.34e-05	0.000185	CbGpPWpGaD
Cyproterone acetate—Nausea—Triamcinolone—hematologic cancer	1.34e-05	6.42e-05	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.34e-05	6.41e-05	CcSEcCtD
Cyproterone acetate—Discomfort—Doxorubicin—hematologic cancer	1.33e-05	6.37e-05	CcSEcCtD
Cyproterone acetate—Anorexia—Epirubicin—hematologic cancer	1.33e-05	6.37e-05	CcSEcCtD
Cyproterone acetate—Dyspnoea—Methotrexate—hematologic cancer	1.33e-05	6.37e-05	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Prednisone—hematologic cancer	1.31e-05	6.3e-05	CcSEcCtD
Cyproterone acetate—Dyspepsia—Methotrexate—hematologic cancer	1.31e-05	6.29e-05	CcSEcCtD
Cyproterone acetate—Hypotension—Epirubicin—hematologic cancer	1.3e-05	6.25e-05	CcSEcCtD
Cyproterone acetate—Vomiting—Betamethasone—hematologic cancer	1.3e-05	6.24e-05	CcSEcCtD
Cyproterone acetate—Vomiting—Dexamethasone—hematologic cancer	1.3e-05	6.24e-05	CcSEcCtD
Cyproterone acetate—Decreased appetite—Methotrexate—hematologic cancer	1.29e-05	6.21e-05	CcSEcCtD
Cyproterone acetate—Rash—Betamethasone—hematologic cancer	1.29e-05	6.19e-05	CcSEcCtD
Cyproterone acetate—Rash—Dexamethasone—hematologic cancer	1.29e-05	6.19e-05	CcSEcCtD
Cyproterone acetate—Oedema—Doxorubicin—hematologic cancer	1.29e-05	6.18e-05	CcSEcCtD
Cyproterone acetate—Dermatitis—Betamethasone—hematologic cancer	1.29e-05	6.18e-05	CcSEcCtD
Cyproterone acetate—Dermatitis—Dexamethasone—hematologic cancer	1.29e-05	6.18e-05	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.29e-05	6.17e-05	CcSEcCtD
Cyproterone acetate—Fatigue—Methotrexate—hematologic cancer	1.28e-05	6.16e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.28e-05	0.000177	CbGpPWpGaD
Cyproterone acetate—Headache—Dexamethasone—hematologic cancer	1.28e-05	6.15e-05	CcSEcCtD
Cyproterone acetate—Headache—Betamethasone—hematologic cancer	1.28e-05	6.15e-05	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—NR3C1—hematologic cancer	1.28e-05	0.000177	CbGpPWpGaD
Cyproterone acetate—Asthenia—Prednisone—hematologic cancer	1.28e-05	6.13e-05	CcSEcCtD
Cyproterone acetate—Shock—Doxorubicin—hematologic cancer	1.27e-05	6.08e-05	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Doxorubicin—hematologic cancer	1.26e-05	6.06e-05	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Doxorubicin—hematologic cancer	1.26e-05	6.06e-05	CcSEcCtD
Cyproterone acetate—Pruritus—Prednisone—hematologic cancer	1.26e-05	6.05e-05	CcSEcCtD
Cyproterone acetate—Tachycardia—Doxorubicin—hematologic cancer	1.26e-05	6.04e-05	CcSEcCtD
Cyproterone acetate—Skin disorder—Doxorubicin—hematologic cancer	1.25e-05	6.01e-05	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Doxorubicin—hematologic cancer	1.25e-05	5.98e-05	CcSEcCtD
Cyproterone acetate—Dyspnoea—Epirubicin—hematologic cancer	1.24e-05	5.96e-05	CcSEcCtD
Cyproterone acetate—Anorexia—Doxorubicin—hematologic cancer	1.23e-05	5.89e-05	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Methotrexate—hematologic cancer	1.23e-05	5.89e-05	CcSEcCtD
Cyproterone acetate—Dyspepsia—Epirubicin—hematologic cancer	1.23e-05	5.88e-05	CcSEcCtD
Cyproterone acetate—Diarrhoea—Prednisone—hematologic cancer	1.22e-05	5.85e-05	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Methotrexate—hematologic cancer	1.22e-05	5.84e-05	CcSEcCtD
Cyproterone acetate—Nausea—Betamethasone—hematologic cancer	1.22e-05	5.83e-05	CcSEcCtD
Cyproterone acetate—Nausea—Dexamethasone—hematologic cancer	1.22e-05	5.83e-05	CcSEcCtD
Cyproterone acetate—Decreased appetite—Epirubicin—hematologic cancer	1.21e-05	5.81e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—NQO1—hematologic cancer	1.21e-05	0.000167	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CD44—hematologic cancer	1.21e-05	0.000167	CbGpPWpGaD
Cyproterone acetate—Hypotension—Doxorubicin—hematologic cancer	1.21e-05	5.78e-05	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.2e-05	5.77e-05	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—AR—hematologic cancer	1.2e-05	0.000166	CbGpPWpGaD
Cyproterone acetate—Fatigue—Epirubicin—hematologic cancer	1.2e-05	5.76e-05	CcSEcCtD
Cyproterone acetate—Constipation—Epirubicin—hematologic cancer	1.19e-05	5.72e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.18e-05	0.000163	CbGpPWpGaD
Cyproterone acetate—Urticaria—Methotrexate—hematologic cancer	1.18e-05	5.67e-05	CcSEcCtD
Cyproterone acetate—Dizziness—Prednisone—hematologic cancer	1.18e-05	5.65e-05	CcSEcCtD
Cyproterone acetate—Abdominal pain—Methotrexate—hematologic cancer	1.18e-05	5.65e-05	CcSEcCtD
Cyproterone acetate—Body temperature increased—Methotrexate—hematologic cancer	1.18e-05	5.65e-05	CcSEcCtD
Cyproterone acetate—AR—Generic Transcription Pathway—MYC—hematologic cancer	1.18e-05	0.000162	CbGpPWpGaD
Cyproterone acetate—Dyspnoea—Doxorubicin—hematologic cancer	1.15e-05	5.51e-05	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Epirubicin—hematologic cancer	1.15e-05	5.51e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—CYCS—hematologic cancer	1.14e-05	0.000158	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal pain—Epirubicin—hematologic cancer	1.14e-05	5.47e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—HSP90AA1—hematologic cancer	1.14e-05	0.000157	CbGpPWpGaD
Cyproterone acetate—Dyspepsia—Doxorubicin—hematologic cancer	1.14e-05	5.44e-05	CcSEcCtD
Cyproterone acetate—Vomiting—Prednisone—hematologic cancer	1.13e-05	5.43e-05	CcSEcCtD
Cyproterone acetate—Rash—Prednisone—hematologic cancer	1.12e-05	5.39e-05	CcSEcCtD
Cyproterone acetate—Dermatitis—Prednisone—hematologic cancer	1.12e-05	5.38e-05	CcSEcCtD
Cyproterone acetate—Decreased appetite—Doxorubicin—hematologic cancer	1.12e-05	5.38e-05	CcSEcCtD
Cyproterone acetate—Headache—Prednisone—hematologic cancer	1.12e-05	5.35e-05	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.11e-05	5.34e-05	CcSEcCtD
Cyproterone acetate—Fatigue—Doxorubicin—hematologic cancer	1.11e-05	5.33e-05	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—MAPK14—hematologic cancer	1.11e-05	0.000153	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—CDKN2B—hematologic cancer	1.11e-05	0.000153	CbGpPWpGaD
Cyproterone acetate—Urticaria—Epirubicin—hematologic cancer	1.11e-05	5.31e-05	CcSEcCtD
Cyproterone acetate—Constipation—Doxorubicin—hematologic cancer	1.1e-05	5.29e-05	CcSEcCtD
Cyproterone acetate—Abdominal pain—Epirubicin—hematologic cancer	1.1e-05	5.28e-05	CcSEcCtD
Cyproterone acetate—Body temperature increased—Epirubicin—hematologic cancer	1.1e-05	5.28e-05	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Methotrexate—hematologic cancer	1.1e-05	5.26e-05	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—ESR1—hematologic cancer	1.09e-05	0.00015	CbGpPWpGaD
Cyproterone acetate—Asthenia—Methotrexate—hematologic cancer	1.07e-05	5.12e-05	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Doxorubicin—hematologic cancer	1.06e-05	5.1e-05	CcSEcCtD
Cyproterone acetate—Nausea—Prednisone—hematologic cancer	1.06e-05	5.08e-05	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.05e-05	5.06e-05	CcSEcCtD
Cyproterone acetate—Pruritus—Methotrexate—hematologic cancer	1.05e-05	5.05e-05	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—NOTCH1—hematologic cancer	1.05e-05	0.000145	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—NCOR1—hematologic cancer	1.05e-05	0.000145	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Epirubicin—hematologic cancer	1.03e-05	4.92e-05	CcSEcCtD
Cyproterone acetate—Urticaria—Doxorubicin—hematologic cancer	1.02e-05	4.91e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.02e-05	0.000141	CbGpPWpGaD
Cyproterone acetate—Abdominal pain—Doxorubicin—hematologic cancer	1.02e-05	4.89e-05	CcSEcCtD
Cyproterone acetate—Body temperature increased—Doxorubicin—hematologic cancer	1.02e-05	4.89e-05	CcSEcCtD
Cyproterone acetate—Diarrhoea—Methotrexate—hematologic cancer	1.02e-05	4.89e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—GSTP1—hematologic cancer	1.01e-05	0.000139	CbGpPWpGaD
Cyproterone acetate—Asthenia—Epirubicin—hematologic cancer	1e-05	4.8e-05	CcSEcCtD
Cyproterone acetate—Pruritus—Epirubicin—hematologic cancer	9.86e-06	4.73e-05	CcSEcCtD
Cyproterone acetate—Dizziness—Methotrexate—hematologic cancer	9.85e-06	4.72e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	9.75e-06	0.000135	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ABCB1—hematologic cancer	9.54e-06	0.000132	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Epirubicin—hematologic cancer	9.54e-06	4.57e-05	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—CREBBP—hematologic cancer	9.53e-06	0.000131	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Doxorubicin—hematologic cancer	9.5e-06	4.56e-05	CcSEcCtD
Cyproterone acetate—Vomiting—Methotrexate—hematologic cancer	9.47e-06	4.54e-05	CcSEcCtD
Cyproterone acetate—Rash—Methotrexate—hematologic cancer	9.39e-06	4.5e-05	CcSEcCtD
Cyproterone acetate—Dermatitis—Methotrexate—hematologic cancer	9.38e-06	4.5e-05	CcSEcCtD
Cyproterone acetate—Headache—Methotrexate—hematologic cancer	9.33e-06	4.47e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—GSTM1—hematologic cancer	9.27e-06	0.000128	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—NCOR1—hematologic cancer	9.27e-06	0.000128	CbGpPWpGaD
Cyproterone acetate—Asthenia—Doxorubicin—hematologic cancer	9.25e-06	4.44e-05	CcSEcCtD
Cyproterone acetate—Dizziness—Epirubicin—hematologic cancer	9.22e-06	4.42e-05	CcSEcCtD
Cyproterone acetate—Pruritus—Doxorubicin—hematologic cancer	9.12e-06	4.38e-05	CcSEcCtD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—MYC—hematologic cancer	8.92e-06	0.000123	CbGpPWpGaD
Cyproterone acetate—Vomiting—Epirubicin—hematologic cancer	8.86e-06	4.25e-05	CcSEcCtD
Cyproterone acetate—Nausea—Methotrexate—hematologic cancer	8.85e-06	4.24e-05	CcSEcCtD
Cyproterone acetate—Diarrhoea—Doxorubicin—hematologic cancer	8.82e-06	4.23e-05	CcSEcCtD
Cyproterone acetate—Rash—Epirubicin—hematologic cancer	8.79e-06	4.21e-05	CcSEcCtD
Cyproterone acetate—Dermatitis—Epirubicin—hematologic cancer	8.78e-06	4.21e-05	CcSEcCtD
Cyproterone acetate—Headache—Epirubicin—hematologic cancer	8.73e-06	4.19e-05	CcSEcCtD
Cyproterone acetate—Dizziness—Doxorubicin—hematologic cancer	8.53e-06	4.09e-05	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—MAPK14—hematologic cancer	8.41e-06	0.000116	CbGpPWpGaD
Cyproterone acetate—Nausea—Epirubicin—hematologic cancer	8.28e-06	3.97e-05	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—ESR1—hematologic cancer	8.25e-06	0.000114	CbGpPWpGaD
Cyproterone acetate—Vomiting—Doxorubicin—hematologic cancer	8.2e-06	3.93e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—MTHFR—hematologic cancer	8.19e-06	0.000113	CbGpPWpGaD
Cyproterone acetate—Rash—Doxorubicin—hematologic cancer	8.13e-06	3.9e-05	CcSEcCtD
Cyproterone acetate—Dermatitis—Doxorubicin—hematologic cancer	8.12e-06	3.9e-05	CcSEcCtD
Cyproterone acetate—Headache—Doxorubicin—hematologic cancer	8.08e-06	3.87e-05	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—NOTCH1—hematologic cancer	7.98e-06	0.00011	CbGpPWpGaD
Cyproterone acetate—Nausea—Doxorubicin—hematologic cancer	7.66e-06	3.67e-05	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—CREBBP—hematologic cancer	7.23e-06	9.98e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	7.22e-06	9.95e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3CG—hematologic cancer	6.88e-06	9.49e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CREBBP—hematologic cancer	6.38e-06	8.8e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3CD—hematologic cancer	6.05e-06	8.34e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ALB—hematologic cancer	5.97e-06	8.23e-05	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—MAPK3—hematologic cancer	5.82e-06	8.02e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3R1—hematologic cancer	5.71e-06	7.88e-05	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—MYC—hematologic cancer	5.66e-06	7.8e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3CB—hematologic cancer	5.27e-06	7.27e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PTEN—hematologic cancer	4.56e-06	6.28e-05	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—MAPK3—hematologic cancer	4.41e-06	6.09e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—EP300—hematologic cancer	4.34e-06	5.99e-05	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—MYC—hematologic cancer	4.29e-06	5.92e-05	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—AKT1—hematologic cancer	3.92e-06	5.41e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3CA—hematologic cancer	3.21e-06	4.43e-05	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—AKT1—hematologic cancer	2.98e-06	4.11e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—AKT1—hematologic cancer	2.63e-06	3.62e-05	CbGpPWpGaD
